KR20230168005A - Red Ginseng Tablet And Preparing Method Thereof - Google Patents
Red Ginseng Tablet And Preparing Method Thereof Download PDFInfo
- Publication number
- KR20230168005A KR20230168005A KR1020220068371A KR20220068371A KR20230168005A KR 20230168005 A KR20230168005 A KR 20230168005A KR 1020220068371 A KR1020220068371 A KR 1020220068371A KR 20220068371 A KR20220068371 A KR 20220068371A KR 20230168005 A KR20230168005 A KR 20230168005A
- Authority
- KR
- South Korea
- Prior art keywords
- red ginseng
- tablets
- powder
- weight
- oil
- Prior art date
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 132
- 238000000034 method Methods 0.000 title description 5
- 239000000843 powder Substances 0.000 claims abstract description 45
- 239000004615 ingredient Substances 0.000 claims abstract description 23
- 239000000314 lubricant Substances 0.000 claims abstract description 23
- -1 sucrose fatty acid ester Chemical class 0.000 claims abstract description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 14
- 239000000194 fatty acid Substances 0.000 claims abstract description 14
- 229930195729 fatty acid Natural products 0.000 claims abstract description 14
- 235000011187 glycerol Nutrition 0.000 claims abstract description 10
- 229930006000 Sucrose Natural products 0.000 claims abstract description 9
- 239000005720 sucrose Substances 0.000 claims abstract description 8
- 239000003921 oil Substances 0.000 claims description 29
- 235000019198 oils Nutrition 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000003463 adsorbent Substances 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 239000007884 disintegrant Substances 0.000 claims description 3
- 239000007888 film coating Substances 0.000 claims description 3
- 238000009501 film coating Methods 0.000 claims description 3
- 239000004014 plasticizer Substances 0.000 claims description 3
- 239000004909 Moisturizer Substances 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- 239000004203 carnauba wax Substances 0.000 claims description 2
- 235000013869 carnauba wax Nutrition 0.000 claims description 2
- MVPICKVDHDWCJQ-UHFFFAOYSA-N ethyl 3-pyrrolidin-1-ylpropanoate Chemical compound CCOC(=O)CCN1CCCC1 MVPICKVDHDWCJQ-UHFFFAOYSA-N 0.000 claims description 2
- 229940075507 glyceryl monostearate Drugs 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims description 2
- 230000001333 moisturizer Effects 0.000 claims description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 229940045902 sodium stearyl fumarate Drugs 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 6
- 230000001766 physiological effect Effects 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 239000000284 extract Substances 0.000 description 45
- 240000004371 Panax ginseng Species 0.000 description 36
- 235000008434 ginseng Nutrition 0.000 description 36
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 35
- 235000003140 Panax quinquefolius Nutrition 0.000 description 35
- 238000000605 extraction Methods 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000012530 fluid Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 238000010030 laminating Methods 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- 238000000194 supercritical-fluid extraction Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229930182494 ginsenoside Natural products 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 241000405911 Rehmannia glutinosa Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 244000126002 Ziziphus vulgaris Species 0.000 description 2
- 210000003056 antler Anatomy 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000020230 cinnamon extract Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940002508 ginger extract Drugs 0.000 description 2
- 235000020708 ginger extract Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 229940032147 starch Drugs 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920003163 Eudragit® NE 30 D Polymers 0.000 description 1
- 229920003151 Eudragit® RL polymer Polymers 0.000 description 1
- 229920003152 Eudragit® RS polymer Polymers 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 241000282374 Puma concolor Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 239000001180 angelica archangelica l. root extract Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229920001531 copovidone Polymers 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960005168 croscarmellose Drugs 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- FSXVSUSRJXIJHB-UHFFFAOYSA-M ethyl prop-2-enoate;methyl 2-methylprop-2-enoate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CCOC(=O)C=C.COC(=O)C(C)=C.CC(=C)C(=O)OCC[N+](C)(C)C FSXVSUSRJXIJHB-UHFFFAOYSA-M 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- FETSQPAGYOVAQU-UHFFFAOYSA-N glyceryl palmitostearate Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O FETSQPAGYOVAQU-UHFFFAOYSA-N 0.000 description 1
- 229940046813 glyceryl palmitostearate Drugs 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000020687 goji berry extract Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001165 hyssopus officinalis l. extract Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000010299 mechanically pulverizing process Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- DNKKLDKIFMDAPT-UHFFFAOYSA-N n,n-dimethylmethanamine;2-methylprop-2-enoic acid Chemical compound CN(C)C.CC(=C)C(O)=O.CC(=C)C(O)=O DNKKLDKIFMDAPT-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 229920003124 powdered cellulose Polymers 0.000 description 1
- 235000019814 powdered cellulose Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1886—Stearic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
본 발명은 홍삼 분말 및 홍삼오일을 포함하는 홍삼 정제를 제공한다. 본 발명에 따른 정제는 홍삼 분말을 고함량으로 포함하고, 여기에 소정량의 홍삼오일을 포함함으로써 자당지방산에스테르, 글리세린지방산에스테르 등의 활택제를 사용하지 않음에도 불구하고 활택제를 사용한 정제와 비교하여 타정성이 유사하거나 더 우수하다. 이와 같은 홍삼 정제는 활택제를 포함하지 않고 홍삼 유래 성분을 고함량으로 포함하므로, 홍삼 유래 성분에 따른 생리활성기능 증진 효과가 극대화될 수 있으며, 일정 지표성분 함량을 위해서 섭취해야 하는 일일 섭취량이 적어지므로 소비자의 부담이 낮아지는 이점이 있다. The present invention provides red ginseng tablets containing red ginseng powder and red ginseng oil. The tablet according to the present invention contains a high content of red ginseng powder and a predetermined amount of red ginseng oil, so that although it does not use lubricants such as sucrose fatty acid ester and glycerin fatty acid ester, it is compared with tablets using a lubricant. Therefore, the tableting properties are similar or better. Since these red ginseng tablets do not contain a lubricant and contain a high content of red ginseng-derived ingredients, the effect of enhancing physiological activity according to the red ginseng-derived ingredients can be maximized, and the daily intake required to achieve a certain index ingredient content is small. This has the advantage of lowering the burden on consumers.
Description
본 발명은 활택제를 포함하지 않는 홍삼 정제 및 이의 제조 방법에 관한 것이다. The present invention relates to red ginseng tablets containing no lubricant and a method for producing the same.
인삼(Panax ginseng C.A. Meyer)은 오갈피나무과(Araliaceae) 인삼속(Panax)에 속하는 다년생 초본으로 한방에서 사용되는 한약재 중의 하나로 달면서 쓴맛이 있고, 따뜻한 기운을 가지고 있으며, 원기를 보하고 비장을 보호하며, 폐를 튼튼하게 해주는 등 본초학적 효능을 가지고 있다. Ginseng (Panax ginseng C.A. Meyer) is a perennial herb belonging to the genus Panax of the Araliaceae family. It is one of the herbal medicines used in oriental medicine. It has a sweet and bitter taste, has a warm energy, restores vitality and protects the spleen, and It has herbal benefits such as strengthening the lungs.
인삼의 주요 생리활성 물질은 진세노사이드라고도 불리는 사포닌과 정유성분, 폴리아세틸렌, 페놀성분, 배당체 및 산성펩타이드 등이 있으며, 그 밖에도 비타민, 당류, 무기질과 같은 다양한 성분들이 함유되어 있다. 일반적인 인삼의 생리활성 효능은 중추신경계의 작용, 면역기능 강화 작용, 항암 작용 등이 보고되어 있다. 특히 진세노사이드는 지금까지 약 40여 종이 발견되고 있으며 중추신경계를 비롯하여 내분비계, 면역계, 대사계 등에 광범위한 영향을 미쳐 신체기능 조절, 즉 생리기능 정상화에 탁월한 효과를 나타내는 것으로 확인되고 있다. 이들 진세노사이드는 서로 비슷한 작용을 하거나 또는 서로 반대되는 작용을 나타내기도 하는데, 특정 성분이 단독으로 또는 여러 종류가 상호작용을 통해서 다양한 효능을 발휘하는 것으로 알려지고 있다.The main physiologically active substances in ginseng include saponins, also called ginsenosides, essential oil components, polyacetylene, phenolic components, glycosides, and acid peptides. In addition, it contains various components such as vitamins, sugars, and minerals. The general physiological effects of ginseng have been reported to include central nervous system activity, immune function strengthening, and anti-cancer activity. In particular, about 40 types of ginsenosides have been discovered so far, and it has been confirmed that they have a wide range of effects on the central nervous system, endocrine system, immune system, and metabolic system, showing an excellent effect in regulating physical functions, that is, normalizing physiological functions. These ginsenosides may have similar or opposing effects, and it is known that certain ingredients exert various effects alone or through interactions of several types.
인삼의 영양성분 중 지용성 성분 함량은 1~2% 정도 함유되어 있다. 인삼 오일에 대한 화학성분 및 생리활성에 관한 연구는 아직 미비한 실정이지만, 최근의 연구에 따르면 홍삼오일은 기존의 다른 식물성 오일과는 차별화된 특이적 성분특성을 가지고 있고 생리활성 효과가 우수한 것으로 평가되며, 따라서 이를 화장료 조성물 또는 건강기능성 식품 조성물에 활용하기 위한 연구가 지속적으로 이루어지고 있다(특허문헌 1). Among the nutrients in ginseng, the fat-soluble component content is about 1-2%. Research on the chemical composition and physiological activity of ginseng oil is still insufficient, but according to recent studies, red ginseng oil has specific ingredient characteristics that are differentiated from other existing vegetable oils and is evaluated to have excellent physiological activity. Therefore, research is continuously being conducted to utilize it in cosmetic compositions or health functional food compositions (Patent Document 1).
지금까지 인삼을 비롯한 한방 제품은 액체 제형의 엑기스 또는 탕약과 같은 형태로 섭취되는 것이 일반적이었으나, 최근 들어 한방 기능성 성분을 용이하게 섭취하도록 하거나 새로운 식감을 통해 먹는 즐거움을 부여하는 등 다양한 이유로 인하여, 이의 정제, 환제, 캡슐형, 젤리형 등 각종 제형에 대한 연구가 활발히 이루어지고 있다(특허문헌 2). Until now, it has been common for oriental herbal products, including ginseng, to be consumed in the form of liquid extracts or decoctions, but recently, for various reasons such as making it easier to consume herbal functional ingredients or giving the pleasure of eating through new textures, Research is being actively conducted on various dosage forms such as tablets, pills, capsules, and jelly types (Patent Document 2).
이와 같은 제형 연구의 일환으로, 본 발명자는 인삼 유래 성분을 주로 포함하고 활택제를 포함하지 않는 홍삼 정제에 대한 연구를 수행하던 중에, 정제 제조시 홍삼오일을 일정량 사용하면 활택제를 사용하지 않아도 타정성이 양호한 정제를 제조할 수 있음을 확인하였다. 이에 따라, 홍삼오일을 이용한 정제 제조 방법에 대하여 연구를 지속하여 본 발명을 완성하였다.As part of such formulation research, the present inventor was conducting research on red ginseng tablets that mainly contain ginseng-derived ingredients and do not contain a lubricant, and found that if a certain amount of red ginseng oil is used when manufacturing tablets, the tablets can be used without using a lubricant. It was confirmed that tablets of good quality could be manufactured. Accordingly, research continued on the tablet manufacturing method using red ginseng oil and the present invention was completed.
본 발명은 활택제를 사용하지 않으면서도 타정성이 양호한 홍삼 정제 및 이의 제조 방법을 제공하는 것을 목적으로 한다. The purpose of the present invention is to provide red ginseng tablets with good tableting properties without using a lubricant and a method for producing the same.
본 발명의 일 양태는 홍삼 분말 및 홍삼오일을 포함하는 홍삼 정제를 제공한다. One aspect of the present invention provides a red ginseng tablet containing red ginseng powder and red ginseng oil.
본 발명의 다른 양태는 홍삼 분말에, 알코올에 분산시킨 홍삼오일을 가하여 혼합하는 단계; 및 상기 혼합물을 타정하는 단계;를 포함하는 홍삼 정제의 제조 방법을 제공한다. Another aspect of the present invention includes adding and mixing red ginseng oil dispersed in alcohol to red ginseng powder; And providing a method for producing red ginseng tablets comprising the step of compressing the mixture into tablets.
본 발명에 따른 정제는 홍삼 분말을 고함량으로 포함하고, 여기에 소정량의 홍삼오일을 포함함으로써 자당지방산에스테르, 글리세린지방산에스테르 등의 활택제를 사용하지 않음에도 불구하고 활택제를 사용한 정제와 비교하여 타정성이 유사하거나 더 우수하다. The tablet according to the present invention contains a high content of red ginseng powder and a predetermined amount of red ginseng oil, so that although it does not use lubricants such as sucrose fatty acid ester and glycerin fatty acid ester, it is compared with tablets using a lubricant. Therefore, the tableting properties are similar or better.
이와 같은 홍삼 정제는 활택제를 포함하지 않고 홍삼 유래 성분을 고함량으로 포함하므로, 홍삼 유래 성분에 따른 생리활성기능 증진 효과가 극대화될 수 있으며, 일정 지표성분 함량을 위해서 섭취해야 하는 일일 섭취량이 적어지므로 소비자의 부담이 낮아지는 이점이 있다. Since these red ginseng tablets do not contain a lubricant and contain a high content of red ginseng-derived ingredients, the effect of enhancing physiological activity according to the red ginseng-derived ingredients can be maximized, and the daily intake required to achieve a certain index ingredient content is small. This has the advantage of lowering the burden on consumers.
도 1은 본 발명의 실시예, 비교예에 따라 제조된 정제의 외관을 촬영한 사진이다. Figure 1 is a photograph of the appearance of tablets manufactured according to Examples and Comparative Examples of the present invention.
이하, 본 발명에 대한 이해를 돕기 위하여 본 발명을 더욱 상세하게 설명한다. Hereinafter, the present invention will be described in more detail to facilitate understanding of the present invention.
본 명세서 및 청구범위에서 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.Terms or words used in this specification and claims should not be construed as limited to their usual or dictionary meanings, and the inventor may appropriately define the concept of terms in order to explain his or her invention in the best way. It must be interpreted with meaning and concept consistent with the technical idea of the present invention based on the principle that it is.
1. 홍삼 정제1. Red ginseng tablets
본 발명은 홍삼 분말 및 홍삼오일을 포함하는 홍삼 정제를 제공한다.The present invention provides red ginseng tablets containing red ginseng powder and red ginseng oil.
본 발명에서 용어 "정제"는 분체를 가압 및 타정하여 일정 형상으로 형성함으로써 사용자가 복용하기 용이하도록 형성한 것을 의미한다. 상기 분체는 정제를 이루는 고체물질의 집합체를 의미하며, 분체의 입자 크기는 약 1-100㎛ 범위일 수 있으나 이에 제한되는 것은 아니다. 분체의 형상은 다양할 수 있으며, 예를 들어 상기 분체는 비늘형(acicular), 다각형(angular), 결정형(crystalline), 나뭇가지형(dentritic), 섬유상(fibrous), 편상(flaky), 입상(granular), 불규칙형(irregular), 구형(spherical) 등으로 형성될 수 있다.In the present invention, the term "tablet" refers to a product formed by pressurizing and compressing powder into a certain shape to make it easy for users to take. The powder refers to an aggregate of solid materials that form a tablet, and the particle size of the powder may be in the range of about 1-100㎛, but is not limited thereto. The shape of the powder may vary, for example, the powder may be scaly, angular, crystalline, dentritic, fibrous, flaky, granular ( It can be formed in granular, irregular, or spherical shapes.
상기 정제는 코팅되지 않은 형태의 나정일 수 있으며, 코팅제로 코팅된 코팅정의 형태일 수 있다. 상기 코팅제는 제한 없이 이용될 수 있으며, 예컨대 네오코트(neocoat)일 수 있다.The tablet may be an uncoated tablet or a coated tablet coated with a coating agent. The coating agent may be used without limitation and may be, for example, neocoat.
상기 홍삼은 인삼을 증숙하여 얻어지고, 상기 인삼은 재배한 것 또는 시판되는 것 등 제한 없이 사용할 수 있다. 상기 인삼은 다양하게 가공된 것을 포함하며, 예를 들면 수삼, 미삼, 흑삼, 산삼, 장뇌삼, 산양삼, 호정화 인삼, 효소 처리된 미삼, 발효 인삼, 홍삼 및 발효 홍삼으로 이루어지는 군으로부터 선택되는 적어도 어느 하나일 수 있으며, 이에 한정되지 않는다. 수삼은 원형을 유지한 생인삼을 말하고, 미삼은 인삼의 가는 뿌리를 말한다. 홍삼은 생인삼을 쪄서 익혀 건조한 것으로 건조 과정에서 갈변 반응이 일어나 담황갈색 내지 적갈색을 띄는 것이다. 흑삼은 홍삼을 더 여러 번 찌고 건조하여 흑색으로 변화한 인삼을 말한다. 산삼은 자생 인삼을 말하며, 장뇌삼은 심어서 기른 산삼을 말한다. 산양삼은 산간의 삼림 하에서 인위적으로 종자나 묘삼을 파종 이식하여 재배한 인삼이다.The red ginseng is obtained by steaming ginseng, and the ginseng can be used without limitation, such as cultivated or commercially available. The ginseng includes various processed products, for example, at least one selected from the group consisting of fresh ginseng, uncooked ginseng, black ginseng, wild ginseng, camphor ginseng, wild ginseng, purified ginseng, enzyme-treated unprocessed ginseng, fermented ginseng, red ginseng, and fermented red ginseng. It may be one, but is not limited to this. Fresh ginseng refers to raw ginseng that has maintained its original form, and uncooked ginseng refers to the thin roots of ginseng. Red ginseng is made by steaming, cooking, and drying raw ginseng. During the drying process, a browning reaction occurs, giving it a light yellow-brown to reddish-brown color. Black ginseng refers to ginseng that has turned black by steaming and drying red ginseng several times. Wild ginseng refers to native ginseng, and camphor ginseng refers to wild ginseng that has been planted and grown. Wild ginseng is ginseng grown artificially by sowing and transplanting seeds or seedlings of ginseng in mountainous forests.
상기 홍삼 분말은 홍삼을 기계적으로 분쇄하여 얻은 홍삼 분쇄 분말 및 홍삼 추출물을 얻은 후 농축 및/또는 건조하여 수득된 홍삼 농축액 분말을 모두 포함하는 의미로 사용된다. The red ginseng powder is used to include both red ginseng powder obtained by mechanically pulverizing red ginseng and red ginseng concentrate powder obtained by concentrating and/or drying the red ginseng extract.
정제 제조에 사용되는 홍삼 분말의 평균입경은 100㎛ 내지 125㎛, 또는 100㎛ 내지 120㎛일 수 있으나, 이에 한정되지 않는다. 또한, 타정에 적합한 입경을 얻기 위하여 상기 홍삼 분말로 과립 공정을 통해 210㎛ 내지 2㎜, 또는 297㎛ 내지 1㎜, 또는 595㎛ 내지 840㎛, 또는 297㎛ 내지 595㎛의 평균입경을 갖는 과립을 형성한 후 타정에 이용할 수 있다. 상기 홍삼 분말이 하한값 미만의 크기일 경우에는 타정시 흐름성에 문제가 발생하거나 정제의 윗부분이 몸체로부터 벗겨지는 캡핑 현상, 정제가 수평으로 갈라져 줄무늬가 생기거나 층상으로 벗겨지는 라미네이팅 현상이 발생할 수 있다. 상기 홍삼 분말이 상한값을 초과할 경우에는 표면이 균일한 정제가 얻어지지 않는 경우가 생길 수 있다. 다만 제조하고자 하는 정제의 원료 구성 및 특징에 따라 사용하는 인삼 분말의 입경은 달라질 수 있다.The average particle diameter of red ginseng powder used to manufacture tablets may be 100㎛ to 125㎛, or 100㎛ to 120㎛, but is not limited thereto. In addition, in order to obtain a particle size suitable for tableting, the red ginseng powder was subjected to a granulation process to produce granules having an average particle size of 210㎛ to 2㎜, or 297㎛ to 1㎜, or 595㎛ to 840㎛, or 297㎛ to 595㎛. After forming, it can be used for tableting. If the size of the red ginseng powder is less than the lower limit, flow problems may occur during tableting, a capping phenomenon in which the top of the tablet peels off from the body, and a laminating phenomenon in which the tablet is split horizontally to form stripes or peel off in layers may occur. If the red ginseng powder exceeds the upper limit, tablets with a uniform surface may not be obtained. However, the particle size of the ginseng powder used may vary depending on the raw material composition and characteristics of the tablet to be manufactured.
홍삼 분쇄 분말을 수득하기 위해 홍삼 분쇄시 분쇄는 통상의 방식에 의할 수 있으며 특별히 제한되지 않는다. 분쇄는 1회 이상 수행될 수 있다.When pulverizing red ginseng to obtain pulverized red ginseng powder, pulverization may be performed in a conventional manner and is not particularly limited. Grinding may be performed more than once.
본 발명에서 추출물은 홍삼으로부터 임의의 방법으로 추출된 물질을 의미하며, 이렇게 추출된 추출액, 이로부터 얻을 수 있는 농축액, 상기 농축액의 건조물 및 분말을 모두 포함하는 의미로 사용된다. In the present invention, extract refers to a substance extracted from red ginseng by any method, and is used to include all of the extract thus extracted, the concentrate obtained therefrom, and the dried product and powder of the concentrate.
본 발명에서 홍삼 추출물은 홍삼 또는 이의 건조물로부터 추출하여 얻을 수 있다. 상기 홍삼으로부터 추출물을 수득할 때, 홍삼 추출물은 홍삼으로부터 통상의 방식으로 수득된 것일 수 있다. 예를 들어, 용매 추출법, 초음파 추출법, 여과법 및 환류 추출법 등 종래 알려진 통상적인 추출 방법을 모두 사용할 수 있으며, 바람직하게는 용매 추출법이나 환류 추출법을 이용함으로써 제조할 수 있다. 상기 추출 과정은 수회 반복할 수 있으며, 이후에 농축 또는 동결건조 등의 단계를 추가적으로 거칠 수 있다. In the present invention, red ginseng extract can be obtained by extracting red ginseng or its dried product. When obtaining an extract from red ginseng, the red ginseng extract may be obtained from red ginseng in a conventional manner. For example, all conventionally known extraction methods such as solvent extraction, ultrasonic extraction, filtration, and reflux extraction can be used. Preferably, it can be prepared by using solvent extraction or reflux extraction. The extraction process can be repeated several times, and then additional steps such as concentration or freeze-drying can be performed.
상기 홍삼으로부터 추출물을 수득할 때, 물, 유기용매, 초임계 유체 및 이들의 혼합물로 이루어진 군으로부터 선택되는 1종 이상을 추출용매로 사용할 수 있다. 상기 유기용매는 알코올, 바람직하게는 C1-C4의 저급 알코올, 헥산(n-헥산), 에테르, 글리세롤, 프로필렌글리콜, 부틸렌글리콜, 에틸아세테이트, 메틸아세테이트, 디클로로메탄, 클로로포름, 에틸아세테이트, 벤젠 및 이들의 혼합용매로 이루어지는 군으로부터 선택되는 어느 하나일 수 있다. 추출은 40℃ 내지 120℃에서 실시될 수 있고, 바람직하게는 40℃ 내지 100℃에서 실시될 수 있으며, 더욱 바람직하게는 50℃ 내지 90℃에서 실시될 수 있으나, 이에 한정되지 아니한다. 추출은 4시간 내지 36시간 동안 실시될 수 있고, 바람직하게는 8시간 내지 24시간 동안 실시될 수 있다. 추출은 3회 내지 12회 실시될 수 있으나, 이에 한정하지 않는다.When obtaining an extract from the red ginseng, at least one selected from the group consisting of water, organic solvent, supercritical fluid, and mixtures thereof can be used as an extraction solvent. The organic solvent is alcohol, preferably lower alcohol of C 1 -C 4 , hexane (n-hexane), ether, glycerol, propylene glycol, butylene glycol, ethyl acetate, methyl acetate, dichloromethane, chloroform, ethyl acetate, It may be any one selected from the group consisting of benzene and mixed solvents thereof. Extraction may be performed at 40°C to 120°C, preferably at 40°C to 100°C, and more preferably at 50°C to 90°C, but is not limited thereto. Extraction can be performed for 4 to 36 hours, preferably 8 to 24 hours. Extraction may be performed 3 to 12 times, but is not limited to this.
상기 홍삼 분말은 상기 홍삼 정제의 총 중량에 대하여 70 내지 99.5 중량%, 또는 75 내지 99.5 중량%, 또는 80 내지 99.5 중량%, 또는 85 내지 99.5 중량%, 또는 90 내지 99.5 중량%, 또는 95 내지 99.5 중량%, 또는 98 내지 99.5 중량%, 또는 98.5 내지 99.3 중량%로 포함될 수 있다. 상기 수치범위를 초과하는 경우 캡핑, 라미네이팅, 정제가 펀치에 부착되는 현상이 나타나 타정성이 낮아질 수 있고, 상기 수치범위 미만인 경우 타정성은 좋아질 수 있으나 그 외 부형제 함량이 높아져 소비자 선호도가 낮아지는 문제가 있다. The red ginseng powder is 70 to 99.5% by weight, or 75 to 99.5% by weight, or 80 to 99.5% by weight, or 85 to 99.5% by weight, or 90 to 99.5% by weight, or 95 to 99.5% by weight, based on the total weight of the red ginseng tablet. It may be included in weight percent, or 98 to 99.5 weight percent, or 98.5 to 99.3 weight percent. If the above numerical range is exceeded, capping, laminating, and tablets may adhere to the punch, which may lower the tableting properties. If the numerical range is below the above numerical range, the tableting properties may improve, but the content of other excipients increases, which lowers consumer preference. There is.
본 발명에서 홍삼오일은 홍삼 또는 홍삼박에서 임의의 방법으로 추출된 오일이다. In the present invention, red ginseng oil is oil extracted from red ginseng or red ginseng peel by any method.
본 발명에서 홍삼박은 인삼을 증숙 및/또는 건조시켜 얻어진 홍삼을 물, 유기용매 등으로 추출하여 이용 후 발생되는 부산물을 의미하는 것으로서, 홍삼박 분말 제형을 포함할 수 있다. 상기 홍삼박 분말은 홍삼박을 물로 세척한 다음 열풍건조하여 분말 제형으로 얻을 수 있다. In the present invention, red ginseng meal refers to a by-product generated after extracting and using red ginseng obtained by steaming and/or drying ginseng with water, organic solvent, etc., and may include a red ginseng meal powder formulation. The red ginseng powder can be obtained in powder form by washing the red ginseng powder with water and then drying it with hot air.
본 발명에서 홍삼오일은 홍삼 또는 홍삼박에 초임계 유체 추출(supercritical fluid extraction)로 홍삼에 함유되어 있는 지용성 성분을 분리 추출함으로써 수득될 수 있다. 초임계 유체 추출은 온도와 압력이 일정 임계점 이상이 되면 나타나는 초임계 유체를 활용한 추출법으로, 높은 용해력, 신속한 물질 이동과 열 이동, 저점도, 고확산계수로 인한 미세공으로의 빠른 침투성과 같이 액체와 기체의 장점이 복합적으로 적용되는 추출 방법이다. 일반적으로 초임계 유체는 온도와 압력의 변화에 따라 용해도와 밀도가 변하는 성질을 가지고 있으므로, 그에 따라 추출물의 활성도도 달라질 수 있다. 이와 같이, 초임계 유체를 이용한 추출 방법은 압력, 온도의 조작에 의해 고밀도 상태의 조건 설정이 가능하기 때문에 분획, 분리 등의 선택성이 뛰어나서 고순도의 천연 유효 성분을 얻을 수 있고, 비교적 저온에서 추출하기 때문에 열에 의한 천연 유효 성분의 손실을 막을 수 있다는 장점이 있다. In the present invention, red ginseng oil can be obtained by separating and extracting the fat-soluble components contained in red ginseng or red ginseng peel through supercritical fluid extraction. Supercritical fluid extraction is an extraction method using a supercritical fluid that appears when the temperature and pressure exceed a certain critical point. The liquid has high dissolving power, rapid material movement and heat transfer, low viscosity, and rapid penetration into micropores due to a high diffusion coefficient. It is an extraction method that combines the advantages of gas and gas. In general, supercritical fluids have the property of changing solubility and density depending on changes in temperature and pressure, so the activity of the extract may vary accordingly. In this way, the extraction method using supercritical fluid allows setting conditions in a high-density state by manipulating pressure and temperature, so it has excellent selectivity for fractionation and separation, allowing high-purity natural active ingredients to be obtained, and can be extracted at a relatively low temperature. Therefore, it has the advantage of preventing loss of natural active ingredients due to heat.
본 발명에서는 초임계 유체로 임계점이 상온에 가깝고, 무독성·불연성이면서 가격이 매우 저렴한 이산화탄소를 이용할 수 있다. 초임계 추출시 온도, 시간, 압력 등의 조건은 필요에 따라 조절될 수 있으며, 그 조건에 대해서는 아래에 상세히 설명한다.In the present invention, carbon dioxide, which has a critical point close to room temperature, is non-toxic and non-flammable, and is very inexpensive, can be used as the supercritical fluid. During supercritical extraction, conditions such as temperature, time, and pressure can be adjusted as needed, and the conditions are explained in detail below.
초임계 유체로 추출시 온도는 40℃ 내지 100℃일 수 있고, 바람직하게는 50℃ 내지 90℃일 수 있으며, 더욱 바람직하게는 60℃ 내지 80℃일 수 있으나, 이에 한정하지 않는다. 추출시 온도가 적정범위를 벗어나면, 추출물의 수율이 감소하고, 생산비용의 증가하여 제품의 원가가 높아지는 단점이 있다.The temperature during extraction with supercritical fluid may be 40°C to 100°C, preferably 50°C to 90°C, and more preferably 60°C to 80°C, but is not limited thereto. If the temperature during extraction is outside the appropriate range, the yield of the extract decreases, production costs increase, and the cost of the product increases.
초임계 유체로 추출시 추출 시간은 0.5시간 내지 10시간일 수 있고, 바람직하게는 1시간 내지 9시간일 수 있으며, 더욱 바람직하게는 2시간 내지 8시간 또는 2시간 내지 5시간일 수 있으나, 이에 한정하지 않는다.When extracting with a supercritical fluid, the extraction time may be 0.5 hours to 10 hours, preferably 1 hour to 9 hours, and more preferably 2 hours to 8 hours or 2 hours to 5 hours. It is not limited.
상기 홍삼오일은 상기 홍삼 정제의 총 중량에 대하여 0.1 내지 5 중량%, 또는 0.3 내지 5 중량%, 또는 0.5 내지 5 중량%, 또는 0.5 내지 2 중량%, 또는 0.7 내지 1.5 중량%로 포함될 수 있다. 상기 수치범위를 초과하는 경우 타정을 위한 과립 형성이 안되는 문제가 있을 수 있고, 상기 수치범위 미만인 경우 캡핑, 라미네이팅, 정제가 펀치에 부착되는 현상이 나타나 타정성이 낮아질 수 있다. The red ginseng oil may be included in an amount of 0.1 to 5% by weight, or 0.3 to 5% by weight, or 0.5 to 5% by weight, or 0.5 to 2% by weight, or 0.7 to 1.5% by weight, based on the total weight of the red ginseng tablet. If it exceeds the above numerical range, there may be a problem with the formation of granules for tableting, and if it is below the above numerical range, capping, laminating, and tablet adhesion to the punch may occur, which may lower tableting properties.
본 발명의 홍삼 정제는 홍삼 분말과 함께 홍삼오일을 이용함으로써, 활택제를 실질적으로 포함하지 않는 것일 수 있다. 상기 활택제는 탈크, 스테아린산 및 그 염류, 자당지방산에스테르, 글리세린지방산에스테르, 라우릴황산나트륨, 수소화식물성오일, 나트륨벤조에이트, 스테아릴푸마르산나트륨, 글리세릴모노스테아레이트, 폴리에틸렌글리콜, 카나우바왁스, 및 이들의 혼합물 등일 수 있으며, 예컨대 자당지방산에스테르 또는 글리세린지방산에스테르일 수 있으나 이에 제한되는 것은 아니다. 본 발명의 정제는 상기에서 나열된 성분들을 활택제로 포함하지 않을 수 있으나, 상기 성분들이 부형제, 활택제, 결합제 등 정제의 제조에 통상적으로 사용되는 첨가제로 사용되는 경우, 상기 성분들도 본 발명의 정제에 포함될 수 있다.The red ginseng tablet of the present invention may contain substantially no lubricant by using red ginseng oil together with red ginseng powder. The lubricant includes talc, stearic acid and its salts, sucrose fatty acid ester, glycerin fatty acid ester, sodium lauryl sulfate, hydrogenated vegetable oil, sodium benzoate, sodium stearyl fumarate, glyceryl monostearate, polyethylene glycol, carnauba wax, and It may be a mixture of these, for example, sucrose fatty acid ester or glycerin fatty acid ester, but is not limited thereto. The tablet of the present invention may not contain the ingredients listed above as a lubricant, but if the ingredients are used as additives commonly used in the manufacture of tablets such as excipients, lubricants, and binders, the ingredients may also be included in the tablet of the present invention. may be included in
상기 "활택제를 실질적으로 포함하지 않는" 것은, 통상적으로 정제의 타정성을 향상시키기 위한 목적에서 상기 활택제를 사용하는 양보다 더 적은 양으로 상기 활택제를 정제에 포함하는 것을 포함한다. 또한, 본 발명의 정제는 상기 활택제를 전혀 포함하지 않거나 통상의 검출/측정 방법을 통해 검출/측정되지 않는 함량으로 포함할 수 있다.The term “substantially containing no lubricant” includes including the lubricant in the tablet in a smaller amount than the amount typically used for the purpose of improving the tabletting properties of the tablet. Additionally, the tablet of the present invention may not contain the above lubricant at all or may contain the lubricant in an amount that is not detected/measured through conventional detection/measurement methods.
본 발명의 정제는 통상적으로 사용되는 활택제 성분을 전혀 포함하지 않거나, 통상적인 활택제 사용량보다 더 적게 포함하면서도, 활택제 성분을 사용한 홍삼 정제와 유사하거나 더 우수한 타정성을 나타낼 수 있다는 특징이 있으며, 충분한 타정성을 나타내면서도 유효성분인 홍삼 유래 성분의 함량을 현저하게 높일 수 있다는 장점이 있다.The tablet of the present invention contains no commonly used lubricant ingredients at all or contains less than the usual amount of lubricant, but has the characteristic of being able to exhibit tableting properties similar to or better than red ginseng tablets using a lubricant ingredient. , it has the advantage of being able to significantly increase the content of red ginseng-derived ingredients, which are active ingredients, while exhibiting sufficient tableting properties.
또한, 상기 홍삼 정제는 필요에 따라 기타 기능성 물질, 부형제, 결합제, 희석제, 붕해제, 흡착제, 보습제, 필름코팅제, 가소제 등의 부가적인 성분을 추가로 포함할 수 있다.In addition, the red ginseng tablet may additionally contain additional ingredients such as other functional substances, excipients, binders, diluents, disintegrants, adsorbents, moisturizers, film coating agents, and plasticizers, as needed.
상기 기타 기능성 물질은 갈근 추출물, 감초 추출물, 건생강 추출물, 계지 추출물, 계피 추출물, 구기자 추출물, 녹각 추출물, 녹용 추출물, 당귀 추출물, 대추 추출물, 두충 추출물, 맥문동 추출물, 복령 추출물, 작약 추출물, 백출 추출물, 복분자 추출물, 사상자 추출물, 산수유 추출물, 상황버섯 추출물, 생강 추출물, 석창포 추출물, 숙지황 추출물, 영지버섯 추출물, 오가피 추출출, 오미자 추출물, 우슬 추출물, 운지버섯 추출물, 음양곽 추출물, 의이인 추출물, 정향 추출물, 대나무잎 추출물, 진피 추출물, 차가버섯 추출물, 천궁 추출물, 홍화자 추출물, 황기 추출물, 황정 추출물, 지황 추추물, 대추 추출물, 산사자 추출물, 육종용 추출물, 백수오 추출물, 토사자 추출물, 배암차즈기 추출물, 나한과 추출물 및 이의 조합으로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다. The other functional substances include kudzu root extract, licorice extract, dried ginger extract, cinnamon extract, cinnamon extract, goji berry extract, antler extract, deer antler extract, angelica root extract, jujube extract, eucalyptus extract, maekmundong extract, bokryeong extract, peony extract, and baekchul extract. , Bokbunja extract, Sasangja extract, Cornus officinalis extract, Sanghwang mushroom extract, Ginger extract, Seokchangpo extract, Rehmannia glutinosa extract, Ganoderma lucidum extract, Acanthopanax extract, Schisandra chinensis extract, Hyssop extract, Fungi mushroom extract, Yin Yang Gwak extract, Uiiin extract, Clove extract, Bamboo leaf extract, dermis extract, chaga mushroom extract, Cheongung extract, Safflower extract, Astragalus extract, Hwangjeong extract, Rehmannia glutinosa extract, jujube extract, Mountain Lion extract, Yuk Jong-yong extract, Baeksu-o extract, Tosa-ja extract, Baeamchazugi extract, Luohan fruit It may include one or more selected from the group consisting of extracts and combinations thereof.
상기 부형제는 유당, 전분, 백당, 포도당, 덱스트린, 만니톨, 소르비톨, 무기염 및 셀룰로오스로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다. The excipient may include one or more selected from the group consisting of lactose, starch, white sugar, glucose, dextrin, mannitol, sorbitol, inorganic salt, and cellulose.
상기 결합제는 전분 페이스트, 설탕 시럽, 젤라틴, 씨엠씨 나트륨(CMC-Na), 아라비아검, 폴리비닐피롤리돈(PVP), 코포비돈, 마크로골, 히드록시프로필셀룰로오스 또는 히드록시프로필 메틸셀룰로스(HPMC)와 같은 셀룰로오스 유도체류; 경질 무수 규산, 합성 규산 알루미늄, 규산 칼슘 또는 마그네슘 메타실리케이트 알루미네이트와 같은 규산염 유도체; 및 인산수소칼슘과 같은 인산염; 탄산칼슘과 같은 탄산염;으로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다.The binder may be starch paste, sugar syrup, gelatin, CMC sodium (CMC-Na), gum arabic, polyvinylpyrrolidone (PVP), copovidone, macrogol, hydroxypropylcellulose or hydroxypropyl methylcellulose (HPMC). Cellulose derivatives such as; Silicate derivatives such as light anhydrous silicic acid, synthetic aluminum silicate, calcium silicate or magnesium metasilicate aluminate; and phosphates such as calcium hydrogen phosphate; It may include one or more types selected from the group consisting of carbonates such as calcium carbonate.
상기 희석제는 탄산칼슘, 인산칼슘, 덱스트린, 덱스트로스, 과당, 글리세릴팔미토스테아레이트, 수크로스, 유당, 포도당, 만니톨, 알칼리토금속류염, 클레이, 폴리에틸렌글리콜, 및 디칼슘포스페이트로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다.The diluent is selected from the group consisting of calcium carbonate, calcium phosphate, dextrin, dextrose, fructose, glyceryl palmitostearate, sucrose, lactose, glucose, mannitol, alkaline earth metal salt, clay, polyethylene glycol, and dicalcium phosphate. It may include one or more selected types.
상기 붕해제는 크로스카르멜로오스(Croscarmellose), 전분 글리콜산 나트륨(Sodium starch glycolate), 씨엠씨 칼슘(CMC-Ca), 크로스포비돈(Crospovidone), 및 알긴산으로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다. The disintegrant may include at least one selected from the group consisting of croscarmellose, sodium starch glycolate, CMC-Ca, crospovidone, and alginic acid. You can.
상기 흡착제는 콜로이달 실리카, 분말형 셀룰로오스(Powdered cellulose) 및 활성탄(Activated charcoal)으로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다. The adsorbent may include one or more selected from the group consisting of colloidal silica, powdered cellulose, and activated charcoal.
상기 보습제는 글리세린, 프로필렌글리콜 및 소르비톨로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다. The moisturizing agent may include one or more selected from the group consisting of glycerin, propylene glycol, and sorbitol.
상기 필름코팅제는 젤라틴, 폴리에틸렌글리콜, 쉘락, 폴리비닐알코올, 폴리비닐피롤리돈, 비닐피롤리돈과 초산비닐의 중합체, 아크릴산에틸메타크릴산메틸메타크릴산 염화트리메틸암모늄에틸공중합체(예컨대, 상품명 유드라짓(Eudragit)RS 또는 RL, 데구사), 메타크릴산메틸아크릴산에틸 공중합체(예컨대, 상품명 유드라짓(Eudragit)NE30D, 데구사), 및 폴리비닐아세틸디메틸아미노아세테이트로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있다.The film coating agent includes gelatin, polyethylene glycol, shellac, polyvinyl alcohol, polyvinylpyrrolidone, polymer of vinylpyrrolidone and vinyl acetate, ethyl acrylate methacrylate methyl methacrylate trimethylammonium ethyl chloride copolymer (e.g., brand name Selected from the group consisting of Eudragit RS or RL, Degussa), methyl methacrylate ethyl acrylate copolymer (e.g. Eudragit NE30D, Degussa), and polyvinylacetyldimethylaminoacetate It may include one or more types.
상기 가소제는 글리콜, 에스테르, 오일, 글리세린, 및 글리세린유도체로 이루어진 군으로부터 선택되는 1종 이상을 포함할 수 있으며, 이 중에서 글리콜은 프로필렌글리콜, 폴리에틸렌글리콜, 또는 이들의 혼합물 등일 수 있고, 에스테르는 프탈산디에틸, 프탈산디부틸, 디부틸세바케이트, 트리에틸시트레이트, 아세틸트리에틸시트레이트, 아세틸트리부틸시트레이트, 트리아세틴, 또는 이들의 혼합물일 수 있다.The plasticizer may include one or more selected from the group consisting of glycol, ester, oil, glycerin, and glycerin derivatives, of which glycol may be propylene glycol, polyethylene glycol, or a mixture thereof, and ester may be phthalic acid. It may be diethyl, dibutyl phthalate, dibutyl sebacate, triethyl citrate, acetyltriethyl citrate, acetyltributyl citrate, triacetin, or mixtures thereof.
상기 부가적인 성분은 상기 홍삼 정제의 총 중량에 대하여 0.2 내지 25 중량%, 또는 0.2 내지 20 중량%, 또는 0.4 내지 15 중량%, 또는 0.4 내지 10 중량%, 또는 0.4 내지 5 중량%로 포함될 수 있다. 상기 수치범위를 충족하는 경우 타정성이 양호하면서도 정제의 외관 또는 기호성을 개선할 수 있다. The additional ingredients may be included in an amount of 0.2 to 25% by weight, or 0.2 to 20% by weight, or 0.4 to 15% by weight, or 0.4 to 10% by weight, or 0.4 to 5% by weight, based on the total weight of the red ginseng tablet. . When the above numerical range is met, tabletting properties are good and the appearance or palatability of the tablet can be improved.
본 발명의 홍삼 정제의 경도는 5 내지 30kp, 또는 10 내지 20kp, 또는 10 내지 15kp일 수 있다.The hardness of the red ginseng tablet of the present invention may be 5 to 30 kp, or 10 to 20 kp, or 10 to 15 kp.
2. 홍삼 정제의 제조 방법2. Manufacturing method of red ginseng tablets
본 발명의 일 양태는, 홍삼 분말에, 알코올에 분산시킨 홍삼오일을 가하여 혼합하는 단계;를 포함하는 홍삼 정제의 제조 방법을 제공한다. One aspect of the present invention provides a method for producing red ginseng tablets, comprising adding and mixing red ginseng oil dispersed in alcohol to red ginseng powder.
상기 홍삼오일을 분산시키기 위한 유기용매로서의 알코올은 알코올 또는 알코올 수용액일 수 있고, 상기 알코올은 C1-C4의 저급 알코올 및 이들의 혼합물로 이루어진 군으로부터 선택되는 1종 이상일 수 있으며, 바람직하게는 에탄올 또는 에탄올 수용액일 수 있다.The alcohol as an organic solvent for dispersing the red ginseng oil may be alcohol or an alcohol aqueous solution, and the alcohol may be at least one selected from the group consisting of C 1 -C 4 lower alcohols and mixtures thereof, preferably It may be ethanol or an aqueous ethanol solution.
본 발명의 방법은 상기 혼합물로 과립물을 형성하는 단계를 더 포함할 수 있다. 상기 과립물을 형성하는 단계는 건식 과립, 습식 과립 등의 방식으로 수행되는 것일 수 있다. 구체적으로, 건식 과립으로 과립화를 할 경우 홍삼 분말 및 홍삼오일을 포함하는 혼합물을 롤러 컴팩터(roller compactor) 등을 사용하여 압착하여 체과하고, 필요에 따라 기타 성분을 후첨하여 혼합한 후에 타정할 수 있다. 과립화를 하지 않고 직타로 하는 경우에는 각 성분들을 혼합하여 곧바로 타정할 수도 있다.The method of the present invention may further include forming granules from the mixture. The step of forming the granules may be performed by dry granulation, wet granulation, etc. Specifically, when granulating with dry granules, the mixture containing red ginseng powder and red ginseng oil is compressed and sieved using a roller compactor, and other ingredients are added and mixed as necessary, and then tableted. You can. In the case of direct compression without granulation, each component can be mixed and compressed directly.
본 발명은 상기 혼합물 또는 과립물을 타정하는 단계를 포함한다. 상기 타정은 본 기술분야의 통상의 기술자에게 공지된 임의의 타정기를 이용하여 타정하는 것일 수 있으며, 예컨대, 타정 압축력이 1 내지 30kN, 2 내지 30kN, 2 내지 15kN, 또는 3 내지 15kN으로 타정하는 것일 수 있다. 예를 들어 GRC-15S(세종), (KTMD, KTMSA, KTSA, KTSS Series(금성산기) 등의 회전식 타정 장비를 사용하여 수행될 수 있다.The present invention includes the step of compressing the mixture or granule. The tableting may be performed using any tablet press known to those skilled in the art, for example, tableting may be performed with a compression force of 1 to 30 kN, 2 to 30 kN, 2 to 15 kN, or 3 to 15 kN. You can. For example, it can be performed using rotary tableting equipment such as GRC-15S (Sejong), (KTMD, KTMSA, KTSA, KTSS Series (Keumseong Sangi), etc.
상기 홍삼 분말 및 홍삼오일에 대하여, 상술한 바와 동일한 내용이 적용될 수 있으므로, 여기에서는 구체적인 설명을 생략한다.Since the same contents as described above can be applied to the red ginseng powder and red ginseng oil, detailed description is omitted here.
이하, 본 발명을 제조예 및 실시예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail through preparation examples and examples.
단, 하기 제조예, 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명의 내용이 하기 제조예 및 실시예에 의해 한정되는 것은 아니다.However, the following preparation examples and examples are only for illustrating the present invention, and the content of the present invention is not limited by the following preparation examples and examples.
실시예Example
제조예 1 - 홍삼 분말Preparation Example 1 - Red ginseng powder
홍삼 10kg에 정제수 10배를 가하여 90±5℃에서 24시간 이상 추출하였다. 추출액을 원심분리 및 농축하여 홍삼농축액을 제조 후 분무-건조기로 건조하여 분말화하였다.10 times the amount of purified water was added to 10kg of red ginseng and extracted at 90±5°C for over 24 hours. The extract was centrifuged and concentrated to prepare red ginseng concentrate, which was then dried using a spray dryer and powdered.
제조예 2 - 홍삼오일Preparation Example 2 - Red ginseng oil
홍삼 또는 수용성 성분을 제거한 홍삼을 건조 및 분쇄한 후 초임계 추출 장치에 투입하여 추출하였다. 추출 된 홍삼 오일을 활성탄 등을 이용하여 여과 후 정제하였다. Red ginseng or red ginseng from which water-soluble components were removed was dried and pulverized and then extracted by placing it in a supercritical extraction device. The extracted red ginseng oil was filtered and purified using activated carbon, etc.
실시예 1 - 홍삼 정제Example 1 - Red ginseng tablets
홍삼분말 300g을 씨드(seed)로 하고 홍삼오일 4.5g과 에탄올수용액 45g을 바인더액으로 하여 유동층조립기(제조사 GLATT, 제품명 Granulator)로 혼합 및 과립화 하였다. 그 후 과립분말을 타정하여 단면의 직경이 약 14.51mm, 두께 4.54mm인 정제를 제조하였다.300g of red ginseng powder was used as a seed, and 4.5g of red ginseng oil and 45g of ethanol aqueous solution were used as a binder solution, and were mixed and granulated using a fluidized bed granulator (manufacturer GLATT, product name Granulator). The granular powder was then compressed into tablets to prepare tablets with a cross-sectional diameter of approximately 14.51 mm and a thickness of 4.54 mm.
실시예 2Example 2
성분 및 배합비를 아래 표 1에 나타낸 바와 같이 달리한 것을 제외하고 실시예 1과 동일한 방법에 의해 실시예 2의 정제를 제조하였다. Tablets of Example 2 were prepared in the same manner as Example 1, except that the ingredients and mixing ratios were changed as shown in Table 1 below.
비교예 1 내지 4 Comparative Examples 1 to 4
비교예 1은 홍삼분말 300g만으로 이루어진 원료를 유동층조립기에 넣고 혼합 및 과립화 하여 정제를 제조하였다. In Comparative Example 1, a raw material consisting of only 300 g of red ginseng powder was placed in a fluidized bed granulator and mixed and granulated to prepare tablets.
비교예 2 내지 4의 경우 홍삼오일, 자당지방산에스테르 또는 글리세린지방산에스테르의 각 성분을 표 1에 나타낸 함량대로 홍삼분말에 직접 투입한 후 유동층조립기로 혼합 및 과립화 하여 정제를 제조하였다. In Comparative Examples 2 to 4, each component of red ginseng oil, sucrose fatty acid ester, or glycerin fatty acid ester was added directly to red ginseng powder in the amounts shown in Table 1, and then mixed and granulated in a fluidized bed granulator to prepare tablets.
실험예 1 - 타정성Experimental Example 1 - Tabletability
실시예 및 비교예의 홍삼 정제의 타정성을 평가하기 위해, 타정 직후 외관을 육안으로 관찰하였으며, 그 외관을 촬영한 사진을 도 1에 나타낸다. In order to evaluate the tableting properties of the red ginseng tablets of Examples and Comparative Examples, the appearance was observed with the naked eye immediately after tableting, and a photograph of the appearance is shown in Figure 1.
상기 도 1의 결과로부터, 실시예 1의 홍삼 정제는 타정성이 우수하고 실시예 2의 홍삼 정제는 타정성이 양호한 것을 확인할 수 있다. From the results shown in FIG. 1, it can be seen that the red ginseng tablet of Example 1 had excellent tableting properties, and the red ginseng tablets of Example 2 had good tableting properties.
반면, 비교예 1의 홍삼 정제는 캡핑, 라미네이팅, 정제가 펀치에 부착되는 현상이 나타나 타정성이 낮았다. 또한, 비교예 2 내지 4의 홍삼 정제는 스티킹이 발생해 타정성이 낮았다. On the other hand, the red ginseng tablet of Comparative Example 1 had low tableting properties due to capping, laminating, and tablet adhesion to the punch. In addition, the red ginseng tablets of Comparative Examples 2 to 4 had low tableting properties due to sticking.
따라서, 본 발명에 따르면 동일한 배합비로 종래의 활택제를 사용했을 때보다 타정성이 우수한 것을 알 수 있으며, 아울러 홍삼 분말, 홍삼오일 등의 홍삼 유래 성분만으로 구성되므로 생리활성증진 효과가 더욱 증대되는 이점이 있다.Therefore, according to the present invention, it can be seen that tabletting properties are superior to those when using a conventional lubricant at the same mixing ratio, and in addition, since it is composed only of red ginseng-derived ingredients such as red ginseng powder and red ginseng oil, the effect of improving physiological activity is further increased. There is.
Claims (8)
홍삼 정제 총 중량을 기준으로,
홍삼 분말 95~99.5중량%; 및
홍삼오일 0.5~5중량%;를 포함하는 홍삼 정제. In claim 1,
Based on the total weight of red ginseng tablets,
95 to 99.5% by weight of red ginseng powder; and
Red ginseng tablets containing 0.5 to 5% by weight of red ginseng oil.
기타 기능성 물질, 부형제, 결합제, 희석제, 붕해제, 흡착제, 보습제, 필름코팅제, 및 가소제로 이루어진 군으로부터 선택되는 1종 이상의 부가적인 성분을 추가로 포함하는 홍삼 정제.In claim 1,
A red ginseng tablet further comprising one or more additional ingredients selected from the group consisting of other functional substances, excipients, binders, diluents, disintegrants, adsorbents, moisturizers, film coating agents, and plasticizers.
홍삼 정제 총 중량을 기준으로,
홍삼 분말 90~99.5중량%;
홍삼오일 0.1~5중량%; 및
부가적인 성분 0.4~5중량%;를 포함하는 홍삼 정제. In claim 3,
Based on the total weight of red ginseng tablets,
90-99.5% by weight of red ginseng powder;
Red ginseng oil 0.1~5% by weight; and
Red ginseng tablets containing 0.4 to 5% by weight of additional ingredients.
상기 홍삼 분말은 홍삼 농축액 분말 및 홍삼 분쇄 분말을 포함하는 홍삼 정제.In claim 1,
The red ginseng powder is a red ginseng tablet containing red ginseng concentrate powder and red ginseng ground powder.
상기 홍삼 정제는 탈크, 스테아린산 및 그 염류, 자당지방산에스테르, 글리세린지방산에스테르, 라우릴황산나트륨, 수소화식물성오일, 나트륨벤조에이트, 스테아릴푸마르산나트륨, 글리세릴모노스테아레이트, 폴리에틸렌글리콜, 카나우바왁스, 및 이들의 혼합물로 이루어진 군으로부터 선택되는 1종 이상의 활택제를 포함하지 않는 홍삼 정제.In claim 1,
The red ginseng tablets include talc, stearic acid and its salts, sucrose fatty acid ester, glycerin fatty acid ester, sodium lauryl sulfate, hydrogenated vegetable oil, sodium benzoate, sodium stearyl fumarate, glyceryl monostearate, polyethylene glycol, carnauba wax, and Red ginseng tablets that do not contain one or more lubricants selected from the group consisting of mixtures thereof.
상기 혼합물을 타정하는 단계;를 포함하는 홍삼 정제의 제조 방법.Adding and mixing red ginseng oil dispersed in alcohol to red ginseng powder; and
A method for producing red ginseng tablets comprising: compressing the mixture into tablets.
상기 혼합 단계에서, 홍삼 분말 95~99.5중량부에 홍삼오일 0.5~5중량부를 가하여 혼합하는 것인 홍삼 정제의 제조 방법.In claim 7,
In the mixing step, 0.5 to 5 parts by weight of red ginseng oil is added to 95 to 99.5 parts by weight of red ginseng powder and mixed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220068371A KR20230168005A (en) | 2022-06-03 | 2022-06-03 | Red Ginseng Tablet And Preparing Method Thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220068371A KR20230168005A (en) | 2022-06-03 | 2022-06-03 | Red Ginseng Tablet And Preparing Method Thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230168005A true KR20230168005A (en) | 2023-12-12 |
Family
ID=89159739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220068371A KR20230168005A (en) | 2022-06-03 | 2022-06-03 | Red Ginseng Tablet And Preparing Method Thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230168005A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100836446B1 (en) | 2007-04-25 | 2008-06-09 | 웅진식품주식회사 | A method for preparing a gelly type of chinese medicine composition |
KR101440675B1 (en) | 2012-06-26 | 2014-09-19 | 주식회사 한국인삼공사 | Composition for Improving Skin Wrinkle Comprising Ginseng Oil as Active Ingredient |
-
2022
- 2022-06-03 KR KR1020220068371A patent/KR20230168005A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100836446B1 (en) | 2007-04-25 | 2008-06-09 | 웅진식품주식회사 | A method for preparing a gelly type of chinese medicine composition |
KR101440675B1 (en) | 2012-06-26 | 2014-09-19 | 주식회사 한국인삼공사 | Composition for Improving Skin Wrinkle Comprising Ginseng Oil as Active Ingredient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102433442B1 (en) | Bitter reishi spore powder and manufacturing method thereof | |
CN102406679B (en) | Traditional Chinese medicine American ginseng buccal tablet | |
WO2013191319A1 (en) | Method for preparing granule or pill containing extract in high concentration | |
KR20090131256A (en) | Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release | |
CN107137376A (en) | A kind of black fruit fructus lycii extract microcapsule and wolfberry formulation prepared therefrom | |
CN109939201A (en) | Composition of relieving alcoholism and protecting liver and its preparation method and application | |
CN101007071A (en) | Traditional Chinese medicine for treating acute and chronic gastroenteritis and bacterial dysentery and its processing technology | |
CN103142916B (en) | Medicament for preventing and treating senile dementia and preparation method thereof | |
KR20230168005A (en) | Red Ginseng Tablet And Preparing Method Thereof | |
CN112914008A (en) | Health-care solid beverage for constitution of qi depression and preparation method thereof | |
CN104606259B (en) | A kind of compound preparation containing lycopene and preparation method thereof | |
CN101190250B (en) | Chewable tablets for preventing and controlling high-altitude disease and preparation method thereof | |
CN108653716A (en) | A kind of tealeaves essence drunk-sobering tablet and preparation method thereof | |
CN106539892B (en) | Radix ranunculi ternati traditional Chinese medicine composition as well as preparation method and application thereof | |
KR102515460B1 (en) | Method For Preparing Tablet Comprising Arginine And Ginseng | |
CN112914097A (en) | Health-care solid beverage for damp-heat constitution and preparation method thereof | |
KR101894540B1 (en) | Composition for improving coenzyme Q10 with extract of Pinellia ternata, Atractylodes macrocephala, Gastrodia elata, Citrus unshiu peel, Poria cocos, Crataegus pinnatifida, Siegesbeckia pubescens Makino and Coptis japonica Makino | |
KR102465280B1 (en) | Lubricant Composition Comprising Red Ginseng Dietary Fiber | |
CN113016969A (en) | Yin deficiency constitution health-care solid beverage and preparation method thereof | |
KR20170143149A (en) | Composition for promoting growth comprising medicinal herb extracts | |
KR102446852B1 (en) | Method Of Preparing Ultrafine Red Ginseng Powder-containing Tablet | |
CN103652902B (en) | Cordyceps sinensis, fructus lycii and Chinese yam chewing tablet and preparation method thereof | |
CN108498563A (en) | A kind of chitosan composite and preparation method thereof | |
KR102402571B1 (en) | Method for Making Chewable Tablet Containing Red Ginseng | |
CN112316125B (en) | Traditional Chinese medicine composition based on hirudin and preparation method of micropills thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |